Who We Are
The Newborn Sepsis Society (NSS) is an international professional organisation founded in 2019 by a group of neonatologists, paediatric infectious disease specialists, and researchers who recognised the urgent need for a dedicated, multidisciplinary approach to neonatal sepsis.
Today, we bring together over 2,500 members from 85 countries, representing neonatology, paediatrics, microbiology, nursing, pharmacy, epidemiology, and global health. Our members work in settings ranging from tertiary NICUs to community health centres in low-resource environments.
We believe that every newborn, regardless of where they are born, deserves timely and effective protection from sepsis. Through collaborative research, evidence-based education, and global advocacy, we are working to make this vision a reality.
Our Journey
Foundation
NSS founded by a consortium of 15 neonatologists from 8 countries at the European Congress of Neonatology.
First Clinical Guidelines Published
Released the inaugural evidence-based guidelines for early-onset neonatal sepsis, endorsed by 12 national paediatric societies.
Global Sepsis Registry Launched
Established a multicenter registry spanning 45 NICUs across 6 continents to track neonatal sepsis epidemiology and outcomes.
1st World Congress on Neonatal Sepsis
Hosted the inaugural congress in Geneva with 800+ attendees, featuring 120 scientific presentations and 15 workshops.
Education Platform Launch
Launched an online learning platform offering accredited courses, reaching 3,000+ healthcare professionals in the first year.
WHO Partnership
Established formal collaboration with WHO to develop global recommendations for neonatal sepsis prevention in low-resource settings.
Updated Guidelines & Biomarker Consensus
Published the updated 2025 guidelines incorporating novel biomarker panels and AI-assisted risk stratification tools.